News
Cogent Biosciences surges 31% on positive data for bezuclastinib in treating systemic mastocytosis. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback